Bioactive Compounds as Potential Agents for Sexually Transmitted Diseases Management: A Review to Explore Molecular Mechanisms of Action
暂无分享,去创建一个
J. Sharifi‐Rad | D. Calina | A. Docea | M. Martorell | J. Rocha | N. Cruz-Martins | C. Quispe | H. M. Melo Coutinho | W. Koch | T. Tumer | Amirhossein Rahavian | Gizem Antika | Paulina Paprocka | P. Helon | Anahita Ansari Djafari | A. L. Alves Borges Leal | Joara Nályda Pereira Carneiro | P. Alarcón-Zapata | Maria Flaviana Bezerra Morais Braga | A. Rahavian
[1] B. Salehi,et al. Cinnamomum Species: Bridging Phytochemistry Knowledge, Pharmacological Properties and Toxicological Safety for Health Benefits , 2021, Frontiers in Pharmacology.
[2] B. Salehi,et al. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence , 2021, Frontiers in Pharmacology.
[3] D. Calina,et al. The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: Cefiderocol , 2021, Frontiers in Pharmacology.
[4] D. Calina,et al. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety , 2020, Toxicology Reports.
[5] B. Salehi,et al. Ficus plants: State of the art from a phytochemical, pharmacological, and toxicological perspective , 2020, Phytotherapy research : PTR.
[6] B. Salehi,et al. Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development , 2020, Immunologic Research.
[7] M. Friedman,et al. Anti-trichomonad activities of different compounds from foods, marine products, and medicinal plants: a review , 2020, BMC Complementary Medicine and Therapies.
[8] D. Calina,et al. COVID-19 vaccines: ethical framework concerning human challenge studies , 2020, DARU Journal of Pharmaceutical Sciences.
[9] Aristidis Tsatsakis,et al. Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review) , 2020, International journal of molecular medicine.
[10] M. Sharifi-Rad,et al. Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds , 2020, International journal of environmental research and public health.
[11] J. Pezzuto,et al. Best practice in research - Overcoming common challenges in phytopharmacological research , 2020 .
[12] B. Salehi,et al. Avocado–Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited , 2020, Biomolecules.
[13] C. Chan,et al. Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination—Review of Current Perspectives , 2019, Journal of oncology.
[14] Sen,et al. Cucurbita Plants: From Farm to Industry , 2019, Applied Sciences.
[15] B. Salehi,et al. Veronica Plants—Drifting from Farm to Traditional Healing, Food Application, and Phytopharmacology , 2019, Molecules.
[16] C. Navarrete-Dechent,et al. Molluscum contagiosum: an update and review of new perspectives in etiology, diagnosis, and treatment , 2019, Clinical, cosmetic and investigational dermatology.
[17] T. Tasca,et al. Nectandra as a renewable source for (+)-α-bisabolol, an antibiofilm and anti-Trichomonas vaginalis compound. , 2019, Fitoterapia.
[18] Chasity E Trammell,et al. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor , 2019, mBio.
[19] Z. Selamoğlu,et al. Cucurbits Plants: A Key Emphasis to Its Pharmacological Potential , 2019, Molecules.
[20] A. Moteetee,et al. Medicinal plants used for the treatment of sexually transmitted infections in the Maseru District, Lesotho: Antimicrobial validation, phytochemical and cytotoxicity studies , 2019, South African Journal of Botany.
[21] B. Salehi,et al. Plant-Derived Bioactives in Oral Mucosal Lesions: A Key Emphasis to Curcumin, Lycopene, Chamomile, Aloe vera, Green Tea and Coffee Properties , 2019, Biomolecules.
[22] M. E. Alvarez-Sánchez,et al. Trichomonicidal activity of a new anthraquinone isolated from the roots of Morinda panamensis Seem , 2019, Drug development research.
[23] M. Fakhar,et al. Medicinal Plants with Anti-Trichomonas vaginalis Activity in Iran: A Systematic Review , 2019, Iranian journal of parasitology.
[24] D. Calina,et al. Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections , 2018, Experimental and therapeutic medicine.
[25] Faik Gökalp. The inhibition effect of garlic‐derived compounds on human immunodeficiency virus type 1 and saquinavir , 2018, Journal of biochemical and molecular toxicology.
[26] M. Friedman,et al. Potato Peels and Their Bioactive Glycoalkaloids and Phenolic Compounds Inhibit the Growth of Pathogenic Trichomonads. , 2018, Journal of agricultural and food chemistry.
[27] D. Calina,et al. Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review) , 2018, International journal of oncology.
[28] Mahdi Delavari,et al. Induction of Apoptosis by Alcoholic Extract of Combination Verbascum thapsus and Ginger officinale on Iranian Isolate of Trichomonas vaginalis , 2018, Iranian journal of parasitology.
[29] D. Calina,et al. Staphylococcus aureus colonisation in patients from a primary regional hospital , 2017, Molecular medicine reports.
[30] J. Staden,et al. Pharmacological properties of extracts from six South African medicinal plants used to treat sexually transmitted infections (STIs) and related infections , 2017 .
[31] B. Foxman,et al. Recurrent vulvovaginal candidiasis. , 2017, Annals of epidemiology.
[32] Charlotte A Gaydos,et al. Mycoplasma genitalium , 2017, The Journal of infectious diseases.
[33] M. Plummer,et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type , 2017, International journal of cancer.
[34] Daniel H. Foil,et al. Secondary Metabolites from the Leaves of the Medicinal Plant Goldenseal (Hydrastis canadensis). , 2017, Phytochemistry letters.
[35] H. Vazini. Anti-Trichomonas vaginalis activity of nano Micana cordifolia and Metronidazole: an in vitro study , 2017, Journal of Parasitic Diseases.
[36] A. Leung,et al. Molluscum Contagiosum: An Update. , 2017, Recent patents on inflammation & allergy drug discovery.
[37] N. Lopes,et al. The Caatinga endemic Manilkara rufula possesses remarkable activity against Trichomonas vaginalis and Tritrichomonas foetus. , 2017, Experimental parasitology.
[38] D. Calina,et al. Antimicrobial resistance development following surgical site infections , 2016, Molecular medicine reports.
[39] M. Moyo,et al. Antimicrobial, antioxidant and cytotoxicity of isolated compounds from leaves of Pappea capensis , 2017 .
[40] P. Mamba,et al. Anti-microbial, anti-Inflammatory and HIV-1 reverse transcriptase activity of selected South African plants used to treat sexually transmitted diseases , 2016 .
[41] M. Cusini,et al. 2016 European guideline on Mycoplasma genitalium infections , 2016, Journal of the European Academy of Dermatology and Venereology.
[42] G. Mena-Rejón,et al. ANTIPROTOZOAL ACTIVITY OF EXTRACTS OF ELAEODENDRON TRICHOTOMUM (CELASTRACEAE) , 2016, African journal of traditional, complementary, and alternative medicines : AJTCAM.
[43] D. Lowy,et al. Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection. , 2016, Journal of the National Cancer Institute.
[44] A. Docea,et al. ETIOLOGICAL DIAGNOSIS AND PHARMACOTHERAPEUTIC MANAGEMENT OF PARAPNEUMONIC PLEURISY , 2016 .
[45] S. Lautenschlager,et al. European guideline for the management of chancroid , 2016 .
[46] J. Sobel. Recurrent vulvovaginal candidiasis. , 1987, American journal of obstetrics and gynecology.
[47] Marleen Temmerman,et al. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting , 2015, PloS one.
[48] S. Kulkarni,et al. Antimicrobial activity of plant extracts against sexually transmitted pathogens , 2015, Natural product research.
[49] N. Cho,et al. Natural Products for the Treatment of Trachoma and Chlamydia trachomatis , 2015, Molecules.
[50] Peter Vickerman,et al. Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012 , 2015, PloS one.
[51] K. Workowski,et al. Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] H. Chesson,et al. The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States , 2014, Sexually transmitted diseases.
[53] H. Yousefi,et al. Chemical composition of essential oil and anti trichomonas activity of leaf, stem, and flower of Rheum ribes L. extracts , 2014, Avicenna journal of phytomedicine.
[54] N. Low,et al. Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines. , 2014, Vaccine.
[55] A. Badawy,et al. In vitro anti-Trichomonas vaginalis activity of Pistacia lentiscus mastic and Ocimum basilicum essential oil , 2015, Journal of Parasitic Diseases.
[56] D. Naidoo,et al. Plants traditionally used individually and in combination to treat sexually transmitted infections in northern Maputaland, South Africa: antimicrobial activity and cytotoxicity. , 2013, Journal of ethnopharmacology.
[57] T. Tasca,et al. Remarkable Anti-Trichomonas vaginalis Activity of Plants Traditionally Used by the Mbyá-Guarani Indigenous Group in Brazil , 2013, BioMed research international.
[58] R. Vargas,et al. Anti-Trichomonas vaginalis activity of Hypericum polyanthemum extract obtained by supercritical fluid extraction and isolated compounds. , 2013, Parasitology international.
[59] S. Cunningham,et al. Pubic hair removal: a risk factor for ‘minor’ STI such as molluscum contagiosum? , 2013, Sexually Transmitted Infections.
[60] S. Garland,et al. A review of clinical trials of human papillomavirus prophylactic vaccines. , 2012, Vaccine.
[61] L. Manhart,et al. Mycoplasma genitalium, an emerging sexually transmitted pathogen. , 2012, Medecine et maladies infectieuses.
[62] P. Klasse. The molecular basis of HIV entry , 2012, Cellular microbiology.
[63] R. Hay,et al. Scabies in the developing world--its prevalence, complications, and management. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[64] R. B. Giordani,et al. First report of anti-Trichomonas vaginalis activity of the medicinal plant Polygala decumbens from the Brazilian semi-arid region, Caatinga , 2011, Parasitology Research.
[65] K. Workowski,et al. Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[66] E. Ho,et al. Syphilis: using modern approaches to understand an old disease. , 2011, The Journal of clinical investigation.
[67] John P. Moore,et al. Inhibition of HIV-1 and M-MLV reverse transcriptases by a major polyphenol (3,4,5 tri-O-galloylquinic acid) present in the leaves of the South African resurrection plant, Myrothamnus flabellifolia , 2011, Journal of enzyme inhibition and medicinal chemistry.
[68] A. Giuliano,et al. Analysis of overdispersed count data: application to the Human Papillomavirus Infection in Men (HIM) Study , 2011, Epidemiology and Infection.
[69] L. Lindholm,et al. On the evolution of the sexually transmitted bacteria Haemophilus ducreyi and Klebsiella granulomatis , 2011, Annals of the New York Academy of Sciences.
[70] D. Taylor-Robinson,et al. Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly , 2011, Clinical Microbiology Reviews.
[71] G. El-Sherbiny,et al. The Effect of Commiphora molmol (Myrrh) in Treatment of Trichomoniasis vaginalis infection , 2011, Iranian Red Crescent medical journal.
[72] J. van Staden,et al. Antimicrobial properties and phenolic contents of medicinal plants used by the Venda people for conditions related to venereal diseases. , 2011, Journal of ethnopharmacology.
[73] S. Lautenschlager,et al. European guideline for the management of chancroid, 2011 , 2011, International journal of STD & AIDS.
[74] E. Stratman,et al. Diagnosis of Atypical Molluscum Contagiosum: The Utility of a Squash Preparation , 2011, Clinical Medicine & Research.
[75] W. Geisler. Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[76] N. Schmidt,et al. A Randomized Treatment Trial: Single Versus 7-Day Dose of Metronidazole for The Treatment of Trichomonas Vaginalis Among HIV-Infected Women , 2010, Journal of acquired immune deficiency syndromes.
[77] M. Forcier,et al. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention , 2010, Dermatologic therapy.
[78] S. V. van Vuuren,et al. An antimicrobial investigation of plants used traditionally in southern Africa to treat sexually transmitted infections. , 2010, Journal of ethnopharmacology.
[79] N. Silverberg,et al. Vertically Transmitted Molluscum Contagiosum Infection , 2010, Pediatrics.
[80] S. Wen,et al. Baicalin suppresses expression of Chlamydia protease-like activity factor in Hep-2 cells infected by Chlamydia trachomatis. , 2009, Fitoterapia.
[81] V. De Maertelaer,et al. Curettage treatment for molluscum contagiosum: a follow‐up survey study , 2008, The British journal of dermatology.
[82] M. Singh,et al. Anti-Trichomonas activity of Sapindus saponins, a candidate for development as microbicidal contraceptive. , 2008, The Journal of antimicrobial chemotherapy.
[83] F. Tangy,et al. In vitro activity of dermaseptin S4 derivatives against genital infections pathogens. , 2008, Regulatory toxicology and pharmacology : RTP.
[84] O. Aiyelaagbe,et al. The Antimicrobial Activity of Jatropha multifida Extracts and Chromatographic Fractions Against Sexually Transmitted Infections , 2008 .
[85] D. Mabey,et al. Global epidemiology and control of Trichomonas vaginalis , 2008, Current opinion in infectious diseases.
[86] W. Weger,et al. Treatment of molluscum contagiosum with a pulsed dye laser: Pilot study with 19 children , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[87] A. Wald,et al. Genital herpes , 2008, The Lancet.
[88] L. Kambizi. Extracts from Aloe ferox and Withania somnifera inhibit Candida albicans and Neisseria gonorrhoea , 2008 .
[89] H. Lawson,et al. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[90] M. Stanley,et al. Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer , 2007, British Journal of Cancer.
[91] K. Workowski,et al. Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[92] J. Richens. Donovanosis (granuloma inguinale) , 2006, Sexually Transmitted Infections.
[93] R. Wolf,et al. Itch and scratch: scabies and pediculosis. , 2006, Clinics in dermatology.
[94] O. Chosidow. Clinical practices. Scabies. , 2006, The New England journal of medicine.
[95] J. van Staden,et al. Antibacterial and antifungal activity of traditional medicinal plants used against venereal diseases in South Africa. , 2006, Journal of ethnopharmacology.
[96] C. Butler,et al. Interventions for cutaneous molluscum contagiosum. , 2006, The Cochrane database of systematic reviews.
[97] Global strategy for the prevention and control of sexually transmitted infections : 2006 – 2015 Key messages , 2006 .
[98] B. Kotowicz,et al. Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases. , 2006, Advances in medical sciences.
[99] J. Jensen,et al. Mycoplasma genitalium: prevalence, clinical significance, and transmission , 2005, Sexually Transmitted Infections.
[100] E. Hook,et al. Chlamydial and Gonococcal Infection in Men Without Polymorphonuclear Leukocytes on Gram Stain: Implications for Diagnostic Approach and Management , 2005, Sexually transmitted diseases.
[101] J. Jensen,et al. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection , 2005, Sexually Transmitted Infections.
[102] V. Tandon,et al. Preliminary Studies on Activity of Ocimum sanctum, Drynaria quercifolia, and Annona squamosa Against Neisseria gonorrhoeae , 2005, Sexually transmitted diseases.
[103] Trends in HIV/AIDS diagnoses--33 states, 2001-2004. , 2005, MMWR. Morbidity and mortality weekly report.
[104] B. Goh,et al. Dark ground microscopy and treponemal serological tests in the diagnosis of early syphilis , 2004, Sexually Transmitted Infections.
[105] M. C. Basualdo,et al. HIV-1 inhibitory compounds from Calophyllum brasiliense leaves. , 2004, Biological & pharmaceutical bulletin.
[106] J. Peipert,et al. Screening for Syphilis Infection: Recommendation Statement , 2004, The Annals of Family Medicine.
[107] M. C. Basualdo,et al. HIV-1 inhibition by extracts of Clusiaceae species from Mexico. , 2004, Biological & pharmaceutical bulletin.
[108] B. Vuylsteke,et al. Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens , 2003, Sexually transmitted infections.
[109] G. Burstein,et al. Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.
[110] Y. Hara,et al. In vitro inhibitory effects of tea polyphenols on the proliferation of Chlamydia trachomatis and Chlamydia pneumoniae. , 2003, Japanese journal of infectious diseases.
[111] F. X. Bosch,et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.
[112] D. Lewis. Chancroid: clinical manifestations, diagnosis, and management , 2003, Sexually transmitted infections.
[113] M. M. Amorim,et al. Tratamento da vaginose bacteriana com gel vaginal de Aroeira (Schinus terebinthifolius Raddi): ensaio clínico randomizado , 2003 .
[114] M. Pontari. Inflammation and anti-inflammatory therapy in chronic prostatitis , 2002 .
[115] N. O’Farrell. Donovanosis , 2002, Sexually transmitted infections.
[116] E. Erbelding,et al. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[117] W. Levine,et al. SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES 2002 , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[118] Michel A Pontari. Inflammation and anti-inflammatory therapy in chronic prostatitis. , 2002, Urology.
[119] D. Mabey. Epidemiology of STIs: worldwide , 2001 .
[120] R. Gilman,et al. 18S Ribosomal DNA-Based PCR for Diagnosis ofTrichomonas vaginalis , 2000, Journal of Clinical Microbiology.
[121] C. Burkhart,et al. An epidemiologic and therapeutic reassessment of scabies. , 2000, Cutis.
[122] K. Lee,et al. Coumarins and bicoumarin from Ferula sumbul: anti-HIV activity and inhibition of cytokine release. , 2000, Phytochemistry.
[123] O. Chosidow. Scabies and pediculosis , 2000, The Lancet.
[124] G. P. Talwar,et al. Polyherbal Formulations with Wide Spectrum Antimicrobial Activity Against Reproductive Tract Infections and Sexually Transmitted Pathogens , 2000, American journal of reproductive immunology.
[125] W. Leong,et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. , 1999, The New England journal of medicine.
[126] B. Foxman,et al. Risk Factors for Vulvovaginal Candidiasis: A Case- Control Study among University Students , 1996, Epidemiology.
[127] J. Sobel,et al. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. , 1995, American journal of obstetrics and gynecology.
[128] G. Ridgway,et al. Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men. , 1993, The Journal of antimicrobial chemotherapy.
[129] L. Corey,et al. Risk Factors for the Sexual Transmission of Genital Herpes , 1992, Annals of Internal Medicine.
[130] John Richens. The diagnosis and treatment of donovanosis (granuloma inguinale). , 1991, Genitourinary medicine.
[131] P. Furr,et al. Development and evaluation of the polymerase chain reaction to detect Mycoplasma genitalium. , 1991, FEMS microbiology letters.
[132] C. Lee,et al. Natural history of HIV and AIDS. , 1990, AIDS care.
[133] A. P. Kiriushchenkov. [Genital candidiasis]. , 1990, Fel'dsher i akusherka.
[134] O. Arya. Donovanosis , 1988 .
[135] K. Holmes,et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications. , 1983, Annals of internal medicine.
[136] W H Foege,et al. Centers for Disease Control , 1981, Journal of public health policy.
[137] L. G. Koss,et al. Cervical Cancer , 1981, Current Topics in Pathology.
[138] J. O. Alexander. Scabies and pediculosis. , 1968, The Practitioner.